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Abstract
Thirteen mono-N-acyl derivatives of 2,6-diaminopimelic acid (DAP)—new potential inhibitors of the dapEencoded N-succinyl-l,l-diaminopimelic acid desuccinylase (DapE; EC 3.5.1.18)—were analyzed and characterized
by infrared (IR) and nuclear magnetic resonance (NMR) spectroscopies and two capillary electromigration
methods: capillary zone electrophoresis (CZE) and micellar electrokinetic chromatography (MEKC). Structural
features of DAP derivatives were characterized by IR and NMR spectroscopies, whereas CZE and MEKC were
applied to evaluate their purity and to investigate their electromigration properties. Effective electrophoretic
mobilities of these compounds were determined by CZE in acidic and alkaline background electrolytes (BGEs)
and by MEKC in acidic and alkaline BGEs containing a pseudostationary phase of anionic detergent sodium
dodecyl sulfate (SDS) or cationic detergent cetyltrimethylammonium bromide (CTAB). The best separation of
DAP derivatives, including diastereomers of some of them, was achieved by MEKC in an acidic BGE
(500 mM acetic acid [pH 2.54] and 60 mM SDS). All DAP derivatives were examined for their ability to
inhibit catalytic activity of DapE from Haemophilus influenzae (HiDapE) and ArgE from Escherichia coli (EcArgE).
None of these DAP derivatives worked as an effective inhibitor of HiDapE, but one derivative—N-fumaryl, Meester-DAP—was found to be a moderate inhibitor of EcArgE, thereby providing a promising lead structure for
further studies on ArgE inhibitors.

Keywords
2,6-Diaminopimelic acid derivatives, Capillary zone electrophoresis, Micellar electrokinetic chromatography,
Enzyme inhibition, IR spectroscopy, NMR spectroscopy
The World Health Organization reported that bacterial infections represent a significant and permanently
growing medical problem around the world due to the increasing number of disease-causing microbes that have
become resistant to currently available antibiotics [1], [2], [3]. In fact, several pathogenic bacteria, some of
which were thought to have been eradicated, have made a significant resurgence due to
bacterial resistance to antibiotics [4], [5]. For example, resistance to tetracyclinesincreased from 0% in 1948 to
98% in 1998 [4], [5], and tuberculosis is currently one of the leading causes of death in adults by an infectious
disease worldwide, which is significant given that death ratesdue to tuberculosis had declined to near

imperceptible levels in industrial nations [6], [7]. According to the Centers for Disease Control and Prevention
(USA), several bacterial strains currently exhibit multidrug resistance, with more than 60% of hospital-acquired
infections in the United States alone caused by the so-called ESKAPE pathogens (Enterococcus
faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas
aeruginosa, and Enterobacter sp.). These findings have stimulated an intensive search for new potent
antimicrobial agents that are active against drug-resistant bacterial strains [5], [8].
Inhibitors of cell wall biosynthesis—vancomycin and β-lactams, to name a couple—have proven to be very
potent antibiotics, evidence that interfering with cell wall synthesis has deleterious effects on bacterial cell
survival. Enzymes that are targeted by these antibiotics tend to be present in all bacteriaand are highly similar in
structure and function. Unfortunately, only two new antibacterial drugs have emerged since 1962. Because
every antibiotic has a finite lifetime given that resistance will ultimately occur, particularly if the same enzymes
are repeatedly targeted, development of new classes of inhibitors that target previously untargeted cellular
enzymes is essential to retain control of infectious disease [5], [8]. As such, antimicrobial peptides have been
introduced as an innate defense system and shown to provide protection against a wide variety
of microorganisms [9], [10], [11], [12]. Another approach targets microbial enzymes, especially those
catalyzing metabolic processes exclusive to bacteria, as potential targets for potent and selective antibiotics [8].
Recently, we described a series of inhibitors for the bacterial enzyme Nα-acetyl-l-ornithine deacetylase
(ArgE),2 which catalyzes the conversion of Nα-acetyl-l-ornithine to l-ornithine in the fifth step of the biosynthetic
pathway for arginine, a necessary step for bacterial growth [13]. Based on bacterial geneticinformation,
the meso-diaminopimelate (mDAP)/lysine biosynthetic pathway (Fig. 1) offers several potential antibacterial
targets that have yet to be explored [14], [15], [16], [17]. One of the products of this pathway, lysine (10), is
required in protein synthesis and is also used in the peptidoglycan layer of gram-positive bacteria cell walls. A
second product, meso-diaminopimelic acid (mDAP) (9), is an essential component of the peptidoglycan cell wall
in gram-negative bacteria, providing a link between polysaccharide strands. It has been shown that deletion of
the gene encoding for one of the enzymes in the mDAP/lysine biosynthetic pathway, the DapE-encoded Nsuccinyl-l,l-diaminopimelic acid desuccinylase (DapE; EC 3.5.1.18) [18], is lethal to Helicobacter
pylori and Mycobacterium smegmatis [19], [20]. Even in the presence of lysine-supplemented media, H.
pylori was unable to grow. Therefore, DapE is essential for cell growth and proliferation and is a part of a
biosynthetic pathway that is the only source of lysine in bacteria. Because there are no similar biosynthetic
pathways in mammals, inhibitors that target one or more of the enzymes in the mDAP/lysine biosynthetic
pathway are hypothesized to exhibit selective toxicity only against bacteria, providing a previously nondescribed
class of antimicrobial agents [14], [21].

Fig.1. Biosynthetic reactions leading from aspartate to lysine: l-aspartate (1); N-succinyl-l,l-diaminopimelate
(7); l,l-diaminopimelate (8); d,l-diaminopimelate (9); l-lysine (10).
With the aim of developing new antimicrobial agents that target DapE enzymes, a methodology for the quick
and efficient preparation of mono-N-acylated 2,6-diaminopimelic acid (DAP) derivatives was recently

reported [22]. These compounds were designed as competitive inhibitors of the mono-N-succinyl–
DAP hydrolysis reaction catalyzed by DapE, in which the structure of the N-linked succinatemoiety was altered to
inhibit the enzyme’s ability to cleave the adjacent amide bond. The syntheses of a series of 13 DAP derivatives
(Table 1) bearing different N-linked acyl side chains comprising (i) a hydrophobic aliphatic or aromatic moiety
(A1–A6), (ii) an aliphatic moiety terminated by a carboxyl group (C1–C4), (iii) an aliphatic moiety terminated by
an ester group (E1–E3), and their purificationand characterization by high-performance liquid
chromatography (HPLC), elemental analysis, and electrospray ionization–mass spectrometry (ESI–MS) were
described previously [22].
Table 1. Name, indication, structural formula, and relative molecular mass (Mr) of 2,6-diaminopimelic acid and
its mono-N-acyl derivatives.
Compound name and indication Structural formula
Mr
2,6-Diaminopimelic acid
190.2

DAP
N-Acetyl-DAP

232.1

A1
N-Isobutyryl-DAP

260.3

A2
N-Butyryl-DAP

260.3

A3
N-Pivalyl DAP

274.3

A4
N-Valeryl-DAP

274.3

A5
N-Benzoyl-DAP

294.2

A6
N-Glutaryl-DAP

304.3

C1
N-3-Me-glutaryl-DAP

318.3

C2
N-3,3-di-Me-glutaryl-DAP

332.4

C3
N-2,3-Tetrafluoro-succinyl-DAP

362.2

C4
N-Fumaryl, Me-ester-DAP

302.3

E1
N-Malonyl, Et-ester-DAP

304.3

E2

N-2-Me-succinyl, Me-ester-DAP

318.3

E3
We report here the analytical characterization of these DAP derivatives in order to confirm their structural
properties using infrared (IR) and 1H and 13C nuclear magnetic resonance (NMR) spectroscopies. We also
performed qualitative and quantitative analysis of each of these compounds by two capillary electromigration
methods: capillary zone electrophoresis (CZE) and micellar electrokinetic chromatography (MEKC). These two
techniques are excellent tools for separation of both ionogenic and electroneutral
compounds [23], [24], [25] and are frequently used for analysis and characterization of amino acids and their
derivatives [26], [27], [28]. In addition, these DAP derivatives were characterized by their
effective electrophoretic mobilities determined by CZE in acidic and alkaline classical or isoelectric background
electrolytes (BGEs) or by MEKC in acidic and alkaline BGEs containing a micellar pseudostationary phase
constituted by the anionic detergent sodium dodecyl sulfate (SDS) or the cationic
detergent cetyltrimethylammonium bromide (CTAB). Finally, all of these DAP derivatives were tested for
their inhibition activity toward both DapE and ArgE.

Materials and methods
Chemicals

All chemicals used were of analytical reagent grade. Tris(hydroxymethyl)aminomethane (Tris) was purchased
from Serva (Heidelberg, Germany). Phosphoric acid (H3PO4), acetic acid (AcOH), and sodium hydroxide (NaOH)
were obtained from Lachema (Brno, Czech Republic). Iminodiacetic acid(IDA) was obtained from Bachem
(Bubendorf, Switzerland). SDS and CTAB were supplied by Fluka (Buchs, Switzerland). Acetonitrile (ACN) was
obtained from Sigma–Aldrich (Prague, Czech Republic) and methanol (MeOH) from Penta (Chrudim, Czech
Republic).

IR and NMR spectroscopies

Fourier transform (FT)-IR spectra (KBr, νmax cm–1) were recorded on a Nicolet 6700 FT-IR instrument (Madison,
WI, USA). 1H and 13C NMR spectra were obtained on a Bruker AVANCE-600 NMR spectrometer (Bruker BioSpin,
Rheinstetten, Germany) using a 5-mm CPTCI cryoprobe (1H at 600.13 MHz, 13C at 150.9 MHz) in dimethyl
sulfoxide (DMSO)-d6 at 300 K. A series of proton 1D (one-dimensional), 2D–COSY (two-dimensional correlation
spectroscopy), 2D–TOCSY (total correlation spectroscopy) (spin-lock time 90 ms), and 2D–ROESY (rotating frame
NOE [nuclear Overhauser effect] spectroscopy) (mixing time 300 ms) spectra were recorded at 27 °C for
complete structural assignment of the observed proton signals. The structural assignment of the 13C signals was
achieved by combining 1D–APT (attached proton test), 2D–H,C–HSQC (heteronuclear single quantum
coherence), and 2D–H,C–HMBC (heteronuclear multiple bond coherence) spectra.

Capillary electromigration methods

CZE and MEKC were performed on a homemade manually operated apparatus for high-performance capillary
electrophoresis [29] equipped with an ultraviolet (UV) absorption photometric detector operating at 206 nm.
Internally untreated fused silica capillary with outer polyimide coating (Polymicro Technologies, Phoenix, AZ,
USA) with inner diameter of 50 μm, outer diameter of 375 μm, total length of 400 mm, and effective length
(from injection to detector) of 290 mm was used for all separations. Data acquisition and evaluation was carried
out by Chromatography and ElectrophoresisStation Clarity (DataApex, Prague, Czech Republic). The analyzed
DAP derivatives were dissolved in the BGE or water in the concentration range 0.5 to 1.1 mg/ml and were
analyzed as cations in acidic BGEs or as anions in alkaline BGEs. The BGEs were passed through a 0.45-μm
Millipore filter (Bedford, MA, USA). The nanoliter sample volumes were introduced into the capillary

hydrodynamically by pneumatically induced pressure (600–1000 Pa) for a period of 3 to 20 s. The applied
separation voltagewas +12 kV or –12 kV (anode or cathode at the injection capillary end), whereas the electric
current was in the range 7.1 to 45.0 μA at an ambient temperature of 22 to 26 °C.

Determination of IC50

The DapE from Haemophilus influenzae (HiDapE) was purified as described previously [18]. IC50 values were
determined using 3 mM N-succinyl-2,6-diaminopimelic acid (mixture of d,d–l,l isoforms, 1:1) as the substrate.
All kinetic experiments were performed in 50 mM Chelex-100-treated sodium phosphatebuffer at pH 7.5 and
25 °C. Catalytic activities were determined by monitoring the initial rates of amidebond cleavage at 225 nm
(ε = 698 M–1 cm–1) in 50 mM phosphate buffer (pH 7.0) on a Shimadzu UV-2600 UV–Vis (ultraviolet–visible)
spectrometer at 25 °C in the presence of two equivalents of Zn(II). Measurements were performed in triplicate
at a minimum of five inhibitor concentrations. Enzyme activities were expressed as units per milligram, where
1 unit is defined as the amount of enzyme that cleaves 1 μmol of dd,ll-N-succinyl-2,6-diaminopimelic acid at
25 °C in 1 min. These data provide a dose–response curve that allows for the concentration required for
50% inhibition (IC50) of DapE to be extracted.
The ArgE from Escherichia coli (EcArgE) was purified as described previously [30]. IC50 values were determined
spectrophotometrically using 2 mM Nα-acetyl-l-ornithine (L-NAO) as the substrate. The rate of LNAO deacetylation was monitored as a decrease in absorbance at 214 nm using a Shimadzu UV-2600 UV–Vis
spectrophotometer at 25 °C. All kinetic experiments were performed in 50 mM Chelex-100-treated sodium
phosphate buffer at pH 7.5 and 25 °C. Initial rates of L-NAO deacetylationwere determined in triplicate at a
minimum of five inhibitor concentrations, providing a dose–response curve from which the concentration
required for 50% inhibition (IC50) of ArgE could be extracted. Catalytic activities were determined with
an error of ±10%.

Results and discussion
IR and NMR spectroscopies

The structural features of the DAP derivatives were characterized by IR and NMR spectroscopies. IR
(KBr, νmax cm–1) spectra of each of the DAP derivatives reveal characteristic bands corresponding to the
functional groups present in these compounds (see Table SI-1 in the online supplementary material)—that is,
broad bands in the range ν(3427–3050 cm–1) due to amino groups and/or carboxylic OH groups, relatively sharp
bands in the ν(1735–1726 cm–1) range due to carboxylic C O groups, and bands in the ν(1670–1630 cm–1)
and ν(1550–1522 cm–1) ranges due to amide I and amide II groups, respectively. The IR spectra also show distinct
C O and/or C F bands at ν ∼ 1200 cm–1 due to trifluoroacetatecounterions, which originate from the
HPLC purification of DAP derivatives where 0.05% (v/v) trifluoroacetic acid was used as an acid modifier of
the mobile phase.
The 1H and 13C chemical shift data for each DAP derivative were assigned according to the following general
formula:

where R indicates the various acyl substituents (see Tables SI-2 and SI-3 in supplementary material). Signals due
to minor isomers (if resolved from a major isomer) are in italics. The series of DAP derivatives examined were
prepared from an enantiomeric/diastereomeric mixture of RS,RS-2,6-diaminopimelic acid, and the mixtures of
two diastereoisomeric forms were also detected. Due to the additional chiral center on the acyl substituent R in
compounds C2 and E3, ratios of four isomerswithout any ascribed priority were estimated.

Capillary electromigration methods
Selection of experimental conditions

The DAP derivatives examined (Table 1) are typical amphoteric compounds containing both acidic (carboxylic)
and basic (amino) groups with different acyl substituents R on one of the two amino groups. Hence, the
experimental conditions for CZE and MEKC analyses and separations of DAP derivatives were selected based on
the general rules for suitable capillary electrophoresis separation conditions for amino acids
and oligopeptides [31], [32], [33], [34], [35] while also taking into account the specific properties of the DAP
derivatives. The selection of BGEs includes the type and concentration of buffer components and pH, and it also
takes into account the solubility and chemical stability of each compound. Effective mobility of weak electrolytes
and ampholytes strongly depends on pH; therefore, pH is one of the most important parameters influencing
separation efficiency and selectivity of the BGEs.
For CZE analysis and separation of amphoteric DAP derivatives, either acidic or alkaline BGEs are suitable.
Therefore, the following BGEs were used: (i) acidic BGEs (pH 2.18–2.54) in which the amino groups are fully
protonated and the carboxylic groups are only partially dissociated, resulting in cationic migration of the DAP
derivatives; and (ii) basic BGEs (pH 8.20–8.64) in which the amino groups are partially protonated and the
carboxylic groups are fully dissociated, resulting in anionic migration of the DAP derivatives. BGE compositions
were also selected with respect to their buffering capacity in order to maintain proper pH in the zone of
migrating analytes (i.e., pH of the BGE was close to the pKa value of the buffering constituent of the BGE). With
the addition of anionic (SDS) or cationic (CTAB) detergents, the same BGEs were also employed for the
separation of DAP derivatives by MEKC. The complete composition and pH of the BGEs used, as well as the
separation voltages and electric currents employed in the CZE and MEKC analyses and separations of DAP
derivatives, are presented in Table 2.
Table 2. Background electrolytes, separation voltage (Usep), and electric current (I) used in CZE and MEKC
methods.
BGE number BGE composition
pH
Method Usep (kV) I (μA)
BGE I
500 mM AcOH
2.54 CZE
12.0
7.1
BGE II
100 mM Tris, 50 mM AcOH
8.20 CZE
12.0
23.3
BGE III
20 mM Tris, 5 mM H3PO4, 50 mM SDS
8.64 MEKC
12.0
18.6
BGE IV
200 mM iminodiacetic acid
2.28 CZE
12.0
35.0
BGE V
50 mM Tris, 100 mM H3PO4
2.18 CZE
12.0
45.0
BGE VI
500 mM AcOH, 60 mM SDS
2.54 MEKC
–12.0
24.0
BGE VII
100 mM Tris, 50 mM AcOH, 5 mM CTAB 8.20 MEKC
–12.0
23.0
BGE VIII
100 mM Tris, 50 mM AcOH, 10 mM CTAB 8.20 MEKC
–12.0
23.5

Determination of purity of DAP derivatives

DAP derivatives were synthesized for the first time; their standard preparations were not available, and for that
reason their purity degree could be quantified only relatively by the relative corrected peak area, PCA [36],
defined by the following relation:
(1) 𝑃𝑃CA(𝑖𝑖) (%)

= ∑𝑛𝑛

𝐴𝐴c,(𝑖𝑖)

𝑖𝑖=1

𝐴𝐴c,(𝑖𝑖)

· 100

where Ac,(i) is the corrected peak area of the i-th component of the given preparation and n is the number of
components of this preparation. Corrected peak area is the peak area normalized (divided) by the migration
time of this peak. This way, defined purity degree is only an approximate measure of analyte purity given that
molar absorption coefficients of the individual components may differ. Nevertheless, with respect to the

expected structural similarity of the admixtures and main synthetic product, it is reasonable to assume similar
values of their molar absorption coefficients and, thus, also a relatively good estimation of the purity degree of
the main product.
Analyses and purity degree determinations were performed by CZE in the acidic BGE I and alkaline BGE II and by
MEKC in the alkaline BGE III. The PCA for each DAP derivative is summarized in Table 3. For all analytes, high
degrees of purity were observed with PCA values in the range 95.0 to ∼100%. For comparison purposes, CE
analyses for the DAP derivatives E1 and C3 in the electrolyte systems BGE I, BGE II, and BGE III are discussed
further. The derivative E1 was found to be highly pure (PCA ∼ 100%) in all three BGEs (Figs. 2A–C and Table 3).
For the DAP derivative C3, one nonidentified admixture (peak x) with lower electrophoretic mobility than that of
the analyte C3 was found in BGE I and BGE II, and its purity was found to be 94.8% in BGE I and 94.1% in BGE II
(Figs. 2D and 2E and Table 3). However, MEKC performed in BGE III revealed three nonidentified minor
admixtures—x1, x2, and x3—and its purity was found to be 90.8% (Fig. 2F and Table 3). These and other
examples show that significant differences in purity were detected, depending on the method (CZE or MEKC)
and BGE used. CZE analyses on analyte C1 in BGEs I and II suggest high purity (PCA ∼ 100%), but MEKC in BGE III
revealed two minor admixtures x1 and x2 and purity of 94.5% (see Figs. SI-1A–C in supplementary material). The
analyte C4 exhibits high purity (PCA ∼ 100%) when analyzed as a cationby CZE in acidic BGE I, but CZE in alkaline
BGE II and MEKC in alkaline BGE III with SDS pseudostationary phase revealed one or two minor admixtures
indicating lower purity—97.1 and 95.0%, respectively (Figs. SI-1D–F) Thus, MEKC in BGE III with SDS seems to be
more efficient for analysis of DAP derivatives than CZE because it was able to separate admixtures, which
remained unrevealed by CZE analyses in BGEs I and II.
Table 3. Purity degree (PCA) of DAP and its mono-N-acyl-DAP derivatives estimated by CZE in BGE I and BGE II and
by MEKC in BGE III.
PCA (%)
Compound BGE I
BGE II
BGE III
pH 2.54 pH 8.20 pH 8.64
DAP
∼100
∼100
∼100
A1
94.5
93.6
93.7
A2
95.8
95.4
96.1
A3
96.6
97.1
97.0
A4
94.3
95.0
95.8
A5
95.6
96.5
95.6
A6
95.2
95.4
96.2
C1
∼100
∼100
94.5
C2
96.9
98.4
93.2
C3
94.8
94.1
90.8
C4
∼100
97.1
95.0
E1
∼100
∼100
∼100
E2
94.3
91.4
95.1
E3
94.4
93.4
95.9
Note. For names and structures of the compounds, see Table 1. For composition of the BGEs, see Table 2.

Fig.2. Analyses of DAP derivatives E1 and C3 by CZE in BGE I and BGE II and by MEKC in BGE III: (A) E1 by CZE in
BGE I; (B) E1 by CZE in BGE II; (C) E1 by MEKC in BGE III; (D) C3 by CZE in BGE I; (E) C3 by CZE in BGE II; (F) C3 by
MEKC in BGE III. Sample injection: hydrodynamic, 10 mbar × 5 s, x, x1, x2, x3, nonidentified admixtures. For DAP
derivative names and structures, see Table 1. The BGE composition and other experimental conditions are given
in Table 2 and in “Materials and Methods”.

Characterization of DAP derivatives

DAP derivatives were also characterized by their effective electrophoretic mobilities in eight BGEs. The
effective electrophoretic mobility at the temperature inside the capillary, meff,T, was determined from the CZE
and MEKC experimental data using the Eq. (2):
(2) 𝑚𝑚eff,𝑇𝑇

=�

1

𝑡𝑡mig

−

1

𝑡𝑡eof

�·

𝐿𝐿eff ·𝐿𝐿tot
𝑈𝑈sep

where tmig is the migration time of the given analyte (s), teof is the migration time of the electroosmotic
flow marker (s), Leff and Ltot are the effective and total capillary lengths (m), respectively, and Usep is the applied
separation voltage (V). CZE and MEKC experiments were performed at different ambient temperatures (22–
26 °C) and variable input power (Joule heat). To compare the observed mobilities, the actual mobility at
temperature T inside the capillary was recalculated to a reference mobility at 25 °C, meff,25, using Eq. (3):
(3) 𝑚𝑚eff,25

= 𝑚𝑚eff,𝑇𝑇 [1 − 0.020(𝑇𝑇 − 25)]

The actual temperature inside the capillary for each BGE was obtained based on the experimentally measured
dependence of temperature increase inside the capillary on the input power (Joule heat) per unit capillary
length as described previously [37].

The values for effective electrophoretic mobilities of DAP derivatives in eight BGEs at 25 °C are presented
in Table 4. These data exhibit a strong dependence of mobilities of DAP derivatives on pH and reflect the
presence of the particular ionogenic groups and the ratio of effective charge versus size (Mr) of these
compounds. Cationic effective electrophoretic mobilities determined by CZE in the acidic BGE I (0.5 M AcOH, pH
2.54) were relatively low at approximately 5.0 MU (MU = mobility unit = 1 × 10–9 m2 V–1 s–1) due to compensation
of the positive charge of the amino group of DAP derivatives by the partially negative charges of their two or
three carboxyl groups. Interestingly, in the C4 DAP derivative, four fluorine atoms in the side chain significantly
increased the acidity of the corresponding carboxyl group, resulting in a prevailing anionic form of this
compound with negative effective mobility even in the acidic BGE I (pH 2.54). In CZE analyses in alkaline BGE II
(100 mM Tris and 50 mM acetic acid, pH 8.20), all analyzed DAP derivatives migrated as anions. The
derivatives A1 to A6 and E1 to E3 exhibited similar moderate negative effective mobilities in the range –13.6 to –
15.7 MU due to similar ratios of their effective charges and molecular masses. The
derivatives C1 to C4 containing the N-acyl substituent with additional free carboxyl groups possessed an
increased negative charge and exhibited enhanced anionic mobilities in the range –23.3 to –25.2 MU for
compounds C1 to C3 and up to –30.4 MU for the most strongly negatively charged derivative C4.

Table 4. Effective electrophoretic mobilities at 25 °C of DAP derivatives determined by CZE in BGEs I, II, IV, and V
and by MEKC in BGEs III, VI, VII, and VIII.
meff,25 × 109 (m2 V–1 s–
1
)
DAP
BGE I
BGE II
BGE III BGE IV BGE V
BGE VI BGE VII BGE
derivative
VIII
pH 2.54
pH
pH
pH
pH
pH
pH
pH 8.20
8.20
8.64
2.28
2.18
2.54
8.20
A1
4.7
−15.7
−14.2
7.3
8.5a
−9.2a
−14.2
−13.0
a
a
8.3
−9.1
A2
5.0
−14.8
−13.6
7.0
7.8a
−16.6a
−11.9
−10.8
a
a
7.7
−16.5
A3
4.8
−14.6
−13.2
7.0
7.9
−17.8a
−11.8
−10.0
a
−17.6
A4
5.0
−14.5
−12.7
6.9
7.9
−21.7
−9.3
−6.8
7.8
A5
4.7
−13.9
−12.2
6.7
7.6
−23.1a
−8.7
−6.1
a
−23.0
A6
4.4
−13.9
−11.4
6.6
8.1
−25.7a
−1.2a
4.9
a
a
−25.6
−0.7
C1
4.1
−25.2
−23.2
6.3
7.0
−10.6
−15.3
−10.5
a
C2
4.3
−24.0
−23.6
6.3
7.4
−14.0
−12.3
−7.4
–15.9a
C3
4.3
−23.3
−22.9
6.2
7.4
−20.6
−8.3
∼0
C4
−2.4
−30.4
−29.6
∼0
−10.3
−12.9
28.0
28,6
a
E1
3.5
−14.0
−11.1
6.0
7.3
−16.0
−9.4
−7.5
−15.8a
E2
4.1
−14.3
−12.1
6.7
7.7a
−19.2
−11.9
−9.4
a
7.6
E3
4.9
−13.6
−11.7
6.9
7.9
−19.2a
−11.5
−9.1
a
−18.9
Note. For DAP derivative names and structures, see Table 1. The BGE composition and other experimental
conditions are given in Table 2 and in Materials and Methods.
a
Effective mobility of resolved diastereomer of DAP derivative.
Similar electromigration behavior was observed in the MEKC analyses of DAP derivatives in BGE III (20 mM Tris,
5 mM H3PO4, and 50 mM SDS, pH 8.64), where derivatives A1 to A6 and E1 to E3exhibited anionic mobilities in
the range –11.1 to –14.2 MU and the mobilities of the compounds C1to C4 achieved values of –22.9 to –
29.6 MU. The small observed difference between mobilities in the micelle-free BGE II and those in the micellecontaining BGE III suggests that the DAP derivatives do not strongly interact with the SDS micellar pseudophase
of BGE III.
In the CZE analyses of DAP derivatives in the isoelectric BGE IV (200 mM IDA, pH 2.28) and in the classical BGE V
(100 mM H3PO4 and 50 mM Tris, pH 2.18), similar structure–mobility relationships of these compounds were
observed as in the BGE I. Slightly higher cationic mobilities were observed in BGEs IV and V (∼6.0–8.0 MU) than
in BGE I (4.0–5.0 MU), which is due to the increased positive charge of the DAP derivatives at lower pH in BGEs
IV and V (pH 2.28 and 2.18) than in BGE I (pH 2.54). The exception to this behavior is compound C4, which
exhibited negative mobility even under strongly acidic conditions in BGEs IV and V.

An interaction between the positively charged DAP derivatives and the negatively charged SDS micellesin acidic
BGE VI (0.5 M AcOH, pH 2.54) resulted in a negatively charged analyte–micelle complex with variable negative
mobilities in the range –9.1 to –25.7 MU for compounds A1 to A6 and E1 to E3 and in the range –10.6 to –
20.6 MU for compounds C1 to C4. In this case, the differences in mobilities did not result from differences in the
charge/size ratio but rather resulted from differences in the hydrophobicities of the analytes and from the
binding strength of their complexes with SDS micelles.
Negative effective charge and negative mobility were observed for nearly all DAP derivatives (with the exception
of A6 and C4) in alkaline media such as BGE VII (100 mM Tris, 50 mM AcOH, and 5 mM CTAB, pH 8.2) and BGE
VIII (100 mM Tris, 50 mM AcOH, and 10 mM CTAB, pH 8.2), although diminished due to their weak interaction
with positively charged CTAB micelles. Slightly lower absolute values of mobilities in BGE VIII as compared with
BGE VII are apparently caused by the higher concentration of CTAB in BGE VIII (10 mM) versus BGE VII (5 mM).
Reverse migration behavior was observed for DAP derivatives containing the aromatic group (A6) in BGE VIII and
the acidic DAP derivative C4 in BGE VII and BGE VIII. These two derivatives form strong complexes with cationic
CTAB micelles, resulting in a positive charge and cationic migration with a low positive mobility (4.9 MU)
for A6 and a high positive mobility (28.0–28.6 MU) for C4. It is worth noting that in some cases
the diastereomers of the DAP derivatives were partially or completely resolved in achiral media—by CZE in BGE
V and by MEKC in BGE VI and BGE VII (see Fig.3, Fig.4 in the next section). Thus, these separations allowed
determination of effective electrophoretic mobilities for both diastereomers (enantiomer pairs) of these
compounds (see Table 4).

Fig.3. MEKC separation of partial mixtures of DAP derivatives in BGE VI: (A) mixture M1 (A1–A3); (B) mixture M2
(A4–A6); (C) mixture M3 (E1–E3); (D) mixture M4 (C1–C4). Sample injection: 10 mbar × 5 s, x, nonidentified
admixtures. For DAP derivative names and structures, see Table 1. The BGE composition and other experimental
conditions are given in Table 2 and in “Materials and Methods”.

Fig.4. MEKC separation of the 11 DAP derivatives in BGE VI. Sample injection: 10 mbar × 5 s, x, nonidentified
admixtures. For DAP derivative names and structures, see Table 1. The BGE composition and other experimental
conditions are given in Table 2 and in “Materials and Methods”.

Separation of DAP derivatives

From the eight BGEs tested, the largest differences in electrophoretic mobilities for DAP derivatives were found
in BGE VI (0.5 M AcOH [pH 2.54] and 60 mM SDS). Consequently, the separation of mixtures of DAP derivatives
was carried out by MEKC in this BGE. First, four partial mixtures of the analytes were constituted according to
similarity of their N-acyl substituent (Table 1). The mixture M1 was constituted from compounds A1 to A3 with
linear and branched C2 and C4 aliphatic acyl groups; mixture M2 from compounds A4 and A5 with linear and
branched C5 aliphatic acyl groups, respectively, and compound A6 with an aromatic acyl group; mixture M3
from compounds E1 to E3containing esterified carboxyl groups; and mixture M4 composed of
compounds C1 to C4, which contain free carboxylic groups. Fig. 3 shows complete MEKC separations for all
components of mixtures M1, M2, and M4, including a complete or partial separation of the diastereomers
of A1, A2, A3, A5, A6, C1, and C2, whereas in mixture M3 a baseline separation of the diastereomers of E1 was
achieved but E2 and E3 and their diastereomers comigrated. The addition of organic modifiers (methanol or
acetonitrile) to the BGE did not improve the separation of these two compounds and their diastereomers.
Finally, using this optimized BGE, a mixture of all DAP derivatives, with the exception of comigrating
derivatives E2 and E3, was separated by MEKC within a short time of 11 min (Fig. 4).

Enzyme inhibition

All DAP derivatives were examined for their ability to inhibit the catalytic activity of HiDapE enzyme. Of the 13
compounds tested, only A1 showed a weak inhibition of the catalytic activity with an IC50value of 17 mM. These
data suggest that the amino moiety of mono-N-succinyl-DAP forms an important interaction within the active
site of DapE given that the acylated amino acids did not inhibit enzymatic activity. Alternatively, the acylated
versions of these amino acids may introduce a repulsive steric interaction because of bulky alkyl groups, thereby
preventing enzyme binding. All of the DAP derivatives were also examined for their ability to inhibit EcArgE.
Some of the DAP derivatives exhibited a weak inhibition toward EcArgE; the best inhibitor was E1, with an
IC50 value of 480 μM, thereby providing a promising lead structure for further studies on ArgE inhibitors. The
other DapE inhibitors that showed a dose-dependent response to EcArgE were A1, C1, and C3, with IC50 values
of 2.63, 2.11, and 1.28 mM, respectively, whereas the remaining DAP derivatives did not inhibit EcArgE. It
implies that both DapE and ArgE active sites possess strict substrate specificity with regard to both functional
groups and stereochemistry.

Conclusions

The data presented here proved that IR and NMR spectroscopies and capillary electromigration methods, CZE
and MEKC, represent powerful tools for structural analysis, purity determination, separation, and
physicochemical characterization of amino acids and their derivatives. Structural features of mono-N-acyl
derivatives of 2,6-DAP were characterized by IR and NMR spectroscopies, whereas purity degree and
effective electrophoretic mobilities of cationic and anionic forms of these compounds in acidic and alkaline
classical or isoelectric BGEs with and without anionic (SDS) or cationic (CTAB) detergents were determined by
CZE and MEKC methods. The best separation of DAP derivatives, including diastereomers of some of them, was
achieved by MEKC in an acidic BGE (500 mM acetic acid, pH 2.54) with micellar pseudophase constituted by
anionic detergent, 60 mM SDS. None of the analyzed DAP derivatives worked as an effective inhibitor of catalytic
activity of the DapE from H. influenza, but one derivative—N-fumaryl, Me-ester-DAP—was found to be a
moderate inhibitor of ArgE from E. coli, thereby providing a promising lead structure for further studies on ArgE
inhibitors.
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Abbreviations used: ArgE, Nα-acetyl-l-ornithine deacetylase; mDAP, meso-diaminopimelate or mesodiaminopimelic acid; DapE, dapE-encoded N-succinyl-l,l-diaminopimelic acid desuccinylase; DAP, 2,6diaminopimelic acid; HPLC, high-performance liquid chromatography; IR, infrared; NMR, nuclear
magnetic resonance; CZE, capillary zone electrophoresis; MEKC, micellar electrokinetic chromatography;
BGE, background electrolyte; SDS, sodium dodecyl sulfate; CTAB, cetyltrimethylammonium bromide;
Tris, tris(hydroxymethyl)aminomethane; H3PO4, phosphoric acid; AcOH, acetic acid; NaOH, sodium
hydroxide; IDA, iminodiacetic acid; ACN, acetonitrile; MeOH, methanol; FT, Fourier transform; UV,
ultraviolet; HiDapE, DapE from Haemophilus influenzae; UV–Vis, ultraviolet–visible; EcArgE, ArgE
from Escherichia coli; L-NAO, Nα-acetyl-l-ornithine; MU, mobility units.
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